4 terminated. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
Follow Myeloid Leukemia: new trials by email Literature Review of Myeloid Leukemia trials Research Report on Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic Malignancies Dasatinib, laboratory biomarker analysis - Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Phase 1 | Terminated | Barbara Ann Karmanos Cancer Institute | 5 | 2012-05-01 | 2020-12-17 |
| Study of IMC-EB10 in Participant With Leukemia IMC-EB10 - Myeloid Leukemia | Phase 1 | Terminated | Eli Lilly and Company | 25 | 2009-06-01 | 2022-12-22 |
| Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid Leukemia AVE9633 - Myeloid Leukemia | Phase 1 | Terminated | Sanofi | 12 | 2007-09-01 | 2009-05-14 |
| Study to Determine the Optimal Biologic Dose of CC-401 in Subjects With High-Risk Myeloid Leukemia CC-401 - Myeloid Leukemia | Phase 1 | Terminated | Celgene Corporation | 36 | 2005-10-01 | 2007-05-15 |
Leukemia, Myeloid (4) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Blast Crisis (1) · Burkitt Lymphoma (1) · Congenital Abnormalities (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Intraocular Lymphoma (1) · Leukemia, Hairy Cell (1) · Leukemia, Large Granular Lymphocytic (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Chronic-Phase (1)
Hematologic Diseases (4) · Hemic and Lymphatic Diseases (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Leukemia (2) · Blood Protein Disorders (1) · Bone Marrow Diseases (1) · Carcinogenesis (1) · Cardiovascular Diseases (1) · Cell Transformation, Neoplastic (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · DNA Virus Infections (1) · Disease Attributes (1) · Epstein-Barr Virus Infections (1)
AVE9633 (1) · CC 401 (1) · Dasatinib (1) · IMC-EB10 (1)
Barbara Ann Karmanos Cancer Institute (1) · Celgene Corporation (1) · Eli Lilly and Company (1) · Sanofi (1)
United States (4) · France (1) · Spain (1)